Recommendations of Treatment Priorities and Long-Term Interventions for BPD Patients in Different Age Groups
DOI:
https://doi.org/10.61173/cbgsq398Keywords:
Borderline Personality Disorder, Treatment, PsychotherapyAbstract
Borderline Personality Disorder (BPD) is a common personality disorder with staple symptoms instability and impulsiveness. It is a progressive disorder that could even last for several decades, and the patients in different ages usually manifest distinct symptoms. However, at present, only a limited number of papers offer guidance on individualized and prolonged treatment for BPD patients. Instead, many of them tend to only regard BPD patients as a single entity and ignore differences among individuals, which is not conducive to the advancement of BPD treatment. Thus, this paper, from the perspective of clinical diagnosis and treatment for BPD patients, divides the patients into three age groups (adolescent, young adult, and older adult). By employing literature review and analyzing based on existing research, this paper provides more targeted suggestions for the treatment of BPD patients in different age groups and puts forward recommendations for implementing multi-modal and long-term interventions for BPD.
References
[1] Wu, Yang, et al. “Changing Trends in the Global Burden of Mental Disorders from 1990 to 2019 and Predicted Levels in 25 Years.” Epidemiology and Psychiatric Sciences, vol. 32, no. 32, 1 Jan. 2023, p. e63, www.cambridge.org/core/journals/ epidemiology-and-psychiatric-sciences/article/changing-trendsin-the-global-burden-of-mental-disorders-from-1990-to-2019- and-predicted-levels-in-25-years/57DCF2F39E8DC9DD19250C 1CE95C24F8, https://doi.org/10.1017/S2045796023000756.
[2] Doering, Stephan. “Borderline Personality Disorder in Patients with Medical Illness: A Review of Assessment, Prevalence, and Treatment Options.” Psychosomatic Medicine, vol. 81, no. 7, 2019, pp. 584–594, www.ncbi. nlm.nih.gov/pubmed/31232916, https://doi.org/10.1097/ PSY.0000000000000724.
[3] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed., Arlington, VA, American Psychiatric Publishing, 2013.
[4] Mulder, Roger, and Peter Tyrer. “Borderline Personality Disorder: A Spurious Condition Unsupported by Science That Should Be Abandoned.” Journal of the Royal Society of Medicine, vol. 116, no. 4, 12 Apr. 2023, p. 014107682311647-014107682311647, https://doi. org/10.1177/01410768231164780.
[5] Li, GuoRong, et al. “Age-Related Differences in Borderline Personality Disorder Traits and Childhood Maltreatment: A Cross-Sectional Study.” Frontiers in Psychiatry, vol. 16, 22 Jan. 2025, https://doi.org/10.3389/fpsyt.2025.1454328.
[6] Soloff, Paul H., and Laurel Chiappetta. “Time, Age, and Predictors of Psychosocial Outcome in Borderline Personality Disorder.” Journal of Personality Disorders, vol. 34, no. 2, Apr. 2020, pp. 145–160, https://doi.org/10.1521/pedi_2018_32_386.
[7] Bozzatello, Paola, et al. “The Role of Trauma in Early Onset Borderline Personality Disorder: A Biopsychosocial Perspective.” Frontiers in Psychiatry, vol. 12, no. 1, 23 Sept. 2021, www.ncbi.nlm.nih.gov/pmc/articles/PMC8495240/, https://doi.org/10.3389/fpsyt.2021.721361.
[8] Kothgassner, Oswald D., et al. “Efficacy of Dialectical Behavior Therapy for Adolescent Self-Harm and Suicidal Ideation: A Systematic Review and Meta-Analysis.” Psychological Medicine, vol. 51, no. 7, 2021, pp. 1–11, www. ncbi.nlm.nih.gov/pmc/articles/PMC8188531/, https://doi. org/10.1017/s0033291721001355.1
[9] Peters, Wilma, et al. “Trauma-Focused Cognitive–Behavioral Therapy (TF-CBT) for Interpersonal Trauma in Transitional- Aged Youth.” Psychological Trauma: Theory, Research, Practice, and Policy, vol. 13, no. 3, Mar. 2021, pp. 313–321, doi. org/10.1037/tra0001016, https://doi.org/10.1037/tra0001016.
[10] Choi-Kain, Lois W., et al. “What Works in the Treatment of Borderline Personality Disorder.” Current Behavioral Neuroscience Reports, vol. 4, no. 1, 3 Feb. 2017, pp. 21–30, link.springer.com/article/10.1007/s40473-017-0103-z, https:// doi.org/10.1007/s40473-017-0103-z.
[11] Pascual, Juan C, et al. “Pharmacological Management of Borderline Personality Disorder and Common Comorbidities.” CNS Drugs, vol. 37, no. 6, 31 May 2023, pp. 489–497, www. ncbi.nlm.nih.gov/pmc/articles/PMC10276775/, https://doi. org/10.1007/s40263-023-01015-6.
[12] Zanarini, M. C., et al. “The 10-Year Course of Psychosocial Functioning among Patients with Borderline Personality Disorder and Axis II Comparison Subjects.” Acta Psychiatrica Scandinavica, vol. 122, no. 2, 25 Feb. 2010, pp. 103–109, https://doi.org/10.1111/j.1600-0447.2010.01543.x.
[13] Videler, Arjan C., et al. “A Life Span Perspective on Borderline Personality Disorder.” Current Psychiatry Reports, vol. 21, no. 7, 4 June 2019, https://doi.org/10.1007/s11920-019- 1040-1.
[14] Khasho, D. A., et al. “The Effectiveness of Individual Schema Therapy in Older Adults with Borderline Personality Disorder: Protocol of a Multiple-Baseline Study.” Contemporary Clinical Trials Communications, vol. 14, 1 June 2019, p. 100330, www.sciencedirect.com/science/ article/pii/S2451865418300929#sec1, https://doi.org/10.1016/ j.conctc.2019.100330.
[15] Dawuda, Ali Sabior, et al. “Borderline Personality Disorder in Older Adults: A Review of the Diagnostic and Treatment Dilemma.” Indian Journal of Clinical Psychiatry., vol. 4, no. 02, 28 Oct. 2024, pp. 42–47, www.ijocp.com/index.php/IJOCP/ article/view/130, https://doi.org/10.54169/ijocp.v4i02.130. Accessed 26 Jan. 2025.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.

This work is licensed under a Creative Commons Attribution 4.0 International License.
